Aoife Caffrey1, Rachelle E Irwin2, Helene McNulty1, J J Strain1, Diane J Lees-Murdock2, Breige A McNulty3, Mary Ward1, Colum P Walsh2, Kristina Pentieva1. 1. Nutrition Innovation Centre for Food and Health and Genomic Medicine Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, United Kingdom. 2. Genomic Medicine Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, United Kingdom. 3. School of Agriculture & Food Science, University College Dublin, Dublin, Ireland.
Abstract
Background: Emerging evidence suggests that maternal folate status can impact cognitive development in childhood. Folate-dependent DNA methylation may provide a biological mechanism to link folate status during pregnancy with cognition in the offspring. Objective: The objective was to investigate the effect of continued folic acid (FA) supplementation beyond the first trimester of pregnancy on DNA methylation in cord blood of epigenetically controlled genes related to brain development and function. Design: Using available cord blood samples (n = 86) from the Folic Acid Supplementation in the Second and Third Trimesters (FASSTT) trial in pregnancy, we applied pyrosequencing techniques to analyze cord blood DNA at 9 candidate loci known to be regulated by methylation, including some previously implicated in observational studies: the widely dispersed retrotransposon long interspersed nuclear element-1 (LINE-1) and 8 single-copy loci (RBM46, PEG3, IGF2, GRB10, BDNF, GRIN3B, OPCML, and APC2). Results: The newborns of mothers who received ongoing FA (400 µg/d) through the second and third trimesters, compared with placebo, had significantly lower overall DNA methylation levels at LINE-1 (56.3% ± 1.7% compared with 57.2% ± 2.1%; P = 0.024), IFG2 (48.9% ± 4.4% compared with 51.2% ± 5.1%; P = 0.021), and BDNF (2.7% ± 0.7% compared with 3.1% ± 0.8%; P = 0.003). The effect of FA treatment on DNA methylation was significant only in female offspring for IGF2 (P = 0.028) and only in males for BDNF (P = 0.012). For GRB10 and GRIN3B, we detected no effect on overall methylation; however, individual cytosine-phosphate-guanine sites showed significant DNA methylation changes in response to FA. Conclusions: Continued supplementation with FA through trimesters 2 and 3 of pregnancy results in significant changes in DNA methylation in cord blood of genes related to brain development. The findings offer a potential biological mechanism linking maternal folate status with neurodevelopment of the offspring, but this requires further investigation using a genome-wide approach. This trial was registered at www.isrctn.com as ISRCTN19917787.
RCT Entities:
Background: Emerging evidence suggests that maternal folate status can impact cognitive development in childhood. Folate-dependent DNA methylation may provide a biological mechanism to link folate status during pregnancy with cognition in the offspring. Objective: The objective was to investigate the effect of continued folic acid (FA) supplementation beyond the first trimester of pregnancy on DNA methylation in cord blood of epigenetically controlled genes related to brain development and function. Design: Using available cord blood samples (n = 86) from the Folic Acid Supplementation in the Second and Third Trimesters (FASSTT) trial in pregnancy, we applied pyrosequencing techniques to analyze cord blood DNA at 9 candidate loci known to be regulated by methylation, including some previously implicated in observational studies: the widely dispersed retrotransposon long interspersed nuclear element-1 (LINE-1) and 8 single-copy loci (RBM46, PEG3, IGF2, GRB10, BDNF, GRIN3B, OPCML, and APC2). Results: The newborns of mothers who received ongoing FA (400 µg/d) through the second and third trimesters, compared with placebo, had significantly lower overall DNA methylation levels at LINE-1 (56.3% ± 1.7% compared with 57.2% ± 2.1%; P = 0.024), IFG2 (48.9% ± 4.4% compared with 51.2% ± 5.1%; P = 0.021), and BDNF (2.7% ± 0.7% compared with 3.1% ± 0.8%; P = 0.003). The effect of FA treatment on DNA methylation was significant only in female offspring for IGF2 (P = 0.028) and only in males for BDNF (P = 0.012). For GRB10 and GRIN3B, we detected no effect on overall methylation; however, individual cytosine-phosphate-guanine sites showed significant DNA methylation changes in response to FA. Conclusions: Continued supplementation with FA through trimesters 2 and 3 of pregnancy results in significant changes in DNA methylation in cord blood of genes related to brain development. The findings offer a potential biological mechanism linking maternal folate status with neurodevelopment of the offspring, but this requires further investigation using a genome-wide approach. This trial was registered at www.isrctn.com as ISRCTN19917787.
Authors: Katja Franke; Bea R H Van den Bergh; Susanne R de Rooij; Nasim Kroegel; Peter W Nathanielsz; Florian Rakers; Tessa J Roseboom; Otto W Witte; Matthias Schwab Journal: Neurosci Biobehav Rev Date: 2020-01-28 Impact factor: 8.989
Authors: Katherine A Sauder; Robyn N Harte; Brandy M Ringham; Patricia M Guenther; Regan L Bailey; Akram Alshawabkeh; José F Cordero; Anne L Dunlop; Erin P Ferranti; Amy J Elliott; Diane C Mitchell; Monique M Hedderson; Lyndsay A Avalos; Yeyi Zhu; Carrie V Breton; Leda Chatzi; Jin Ran; Irva Hertz-Picciotto; Margaret R Karagas; Vicki Sayarath; Joseph Hoover; Debra MacKenzie; Kristen Lyall; Rebecca J Schmidt; Thomas G O'Connor; Emily S Barrett; Karen M Switkowski; Sarah S Comstock; Jean M Kerver; Leonardo Trasande; Frances A Tylavsky; Rosalind J Wright; Srimathi Kannan; Noel T Mueller; Diane J Catellier; Deborah H Glueck; Dana Dabelea Journal: J Nutr Date: 2021-11-02 Impact factor: 4.687
Authors: Marion Lecorguillé; Marie-Aline Charles; Johanna Lepeule; Sandrine Lioret; Blandine de Lauzon-Guillain; Anne Forhan; Jörg Tost; Matthew Suderman; Barbara Heude Journal: Epigenetics Date: 2021-08-31 Impact factor: 4.861
Authors: Padma Maruvada; Patrick J Stover; Joel B Mason; Regan L Bailey; Cindy D Davis; Martha S Field; Richard H Finnell; Cutberto Garza; Ralph Green; Jean-Louis Gueant; Paul F Jacques; David M Klurfeld; Yvonne Lamers; Amanda J MacFarlane; Joshua W Miller; Anne M Molloy; Deborah L O'Connor; Christine M Pfeiffer; Nancy A Potischman; Joseph V Rodricks; Irwin H Rosenberg; Sharon A Ross; Barry Shane; Jacob Selhub; Sally P Stabler; Jacquetta Trasler; Sedigheh Yamini; Giovanna Zappalà Journal: Am J Clin Nutr Date: 2020-11-11 Impact factor: 7.045
Authors: José Alejandro Roque-Jiménez; German David Mendoza-Martínez; Anayeli Vázquez-Valladolid; María de la Luz Guerrero-González; Rogelio Flores-Ramírez; Juan Manuel Pinos-Rodriguez; Juan J Loor; Alejandro Enrique Relling; Héctor Aarón Lee-Rangel Journal: Animals (Basel) Date: 2020-07-27 Impact factor: 2.752
Authors: Erica C Jansen; Dana Dolinoy; Karen E Peterson; Louise M O'Brien; Ronald D Chervin; Alejandra Cantoral; Martha María Tellez-Rojo; Maritsa Solano-Gonzalez; Jaclyn Goodrich Journal: Epigenetics Date: 2020-10-04 Impact factor: 4.528